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Abstract  
Chestnut trees are one of the most important crops in the North-eastern part of Portugal, 
representing millions of euros of yearly income. There are many ancestral claims of the 
health benefits of the consumption of chestnut flowers in infusions that remain 
unproven. In this manuscript, the antitumor and antimicrobial potential of chestnut 
flowers from two cultivars, Judia and Longal, extracted through infusions and 
decoctions are reported. In terms of antitumor activity, the most sensitive cell lines were 
HepG2 and HCT15 with the cultivar Judia showing higher activity for HCT15 and 
Longal for HepG2, regardless of the extraction methods. Regarding the antibacterial 
activity of the extracts, decoctions proved to be more effective with lower minimum 
inhibition concentrations, while infusions were better in terms of antifungal activity. 
The good overall antimicrobial activity could justify the inclusion of the flowers in food 
chain processing to act as a natural antimicrobial. Furthermore, the results corroborate 
some of the ancestral claims of the consumption of these flowers. 
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1. Introduction 
Chestnut is one of the most important source of income for the North-eastern section of 
Portugal, where almost 85% of total chestnut trees are grown, being chestnut fruits 
almost entirely exported to European markets. The chestnut honey made from flowers is 
highly appreciated, although the most appreciated commodity is the nut of this tree. 
Ancestral claims report that “teas” of chestnut leaves and flowers are used for medicinal 
purposes, namely as mucolytic, antispasmodic and anti-dysenteric treatments, among 
others (Neves et al., 2009). Our research group has been working with chestnut fruits 
(Carocho et al., 2012), flowers (Barros et al., 2010) and leaves, with very good results 
regarding antioxidant (Carocho et al., 2014) and anti-candida (Barros et al., 2013) 
activity of the flowers. Recently, we have also reported the profile in phenolic 
compounds and antioxidant properties of flower decoctions and infusions, in which the 
most prevalent molecules were trigalloyl-HHDP-glucoside and pentagalloyl glucoside 
(Carocho et al., 2014).  
The pressing search for new treatments and drugs for diseases has been increasing in 
recent years. Today, more than 60% of cancer drugs derive from natural products, 
which turn the spotlight on plants and other natural resources (Gordaliza, 2007). Of 
these compounds, many come from the secondary metabolism of plants, like terpenes, 
alcaloids and phenolic compounds. There are many effects that these compounds 
display towards tumours; namely the complete inhibition of growth, apoptosis 
induction, suppression of the secretion of matrix metalloproteinases and reduction of 
tumor invasive behavior (Carocho and Ferreira, 2013). The same issue occurs in the 
search for antimicrobial drugs, with resistance to antibiotics and antifungals rising in 
recent years along with a decrease in the supply of new drugs for these microorganisms. 
More interest has been placed on extracts from natural matrices for their chemical 
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diversity and, in some cases, very potent actions against pathogens with known 
resistance to specific drugs (Saleem et al., 2010). Although some gallotannins have 
displayed some in vitro antitumor and antiproliferative activities (Zhang et al., 2009), as 
well as effective inhibition of some bacterial pathogens (Engels et al., 2009), to the 
authors knowledge, this is the first report on the antitumor and antimicrobial activities 
of decoctions and infusions of chestnut flowers of the most important cultivars in the 
European market, Judia and Longal. 
 
2. Materials and Methods 
2.1. Standards and reagents 
Fetal bovine serum (FBS), L-glutamine, nonessential amino acids solution (2 mM), 
penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively), RPMI-1640 
and Dulbecco's Modified Eagle Medium (DMEM) media were acquired from Thermo 
Fischer Scientific (Waltham, MA, USA). Ellipticine and sulforhodamine B were 
purchased from Sigma Chemical Co. (Saint Louis, MO, USA). All other chemicals 
were purchased at specialized laboratory retailers. Water was treated in a Milli-Q water 
purification system (TGI Pure Water Systems, Greenville, SC, USA).  
 
2.2. Chestnut flower samples and preparation of decoctions and infusions  
Castanea sativa Mill. flowers were collected in June 2013 near Oleiros, Bragança 
(northeastern Portugal) (41°51′02″N, 6°49′54″W). Two cultivars were chosen, Longal 
and Judia, for the representative expression of their fruits (chestnuts) in the Portuguese 
and European market. The samples were then lyophilized (FreeZone 4.5, Labconco, 
Kansas, KS, USA) and subsequently milled down to a fine powder and mixed to obtain 
a homogenate sample.  
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For the infusions, the lyophilized samples (1 g) were added to 200 mL of boiling 
distilled water and left to stand for 5 min, and finally filtered through a Whatman filter 
paper No. 4. For the decoctions, the lyophilized samples (1 g) were added to 200 mL of 
distilled water, heated to boiling point and maintained at this state for 5 min. The 
mixture was then left to stand at room temperature for 5 min more, and then filtered 
through a Whatman filter paper No. 4. The obtained infusions and decoctions were then 
frozen, lyophilized and dissolved in water or 5% DMSO (final concentration 10 
mg/mL) for in vitro evaluation of antitumor and antimicrobial activities, respectively. 
The final solutions were further diluted to different concentrations, ranging from 500 to 
1,95 µg/mL, 50 to 450 µg/mL and 30 to 1000 µg/mL for antitumor, antibacterial and 
antifungal activities evaluation, respectively.   
 
2.3. Antitumor activity and hepatotoxicity 
The antitumor activity was evaluated by the Sulphorhodamine B assay that has been 
previously described by Guimarães et al. (2013), in which four human tumor cell lines 
were tested: MCF7 (breast adenocarcinoma), HCT15 (colon carcinoma), HeLa (cervical 
carcinoma) and HepG2 (hepatocellular carcinoma). The positive control used was 
Ellipticine. These cells were maintained as adherent cell cultures in RPMI-1640 
medium containing 10% heat-inactivated FBS and 2 mM glutamine (MCF7 and 
HCT15) or in DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL 
penicillin and 100 mg/mL streptomycin (HeLa and HepG2 cells), at 37 ºC, in a 
humidified air incubator containing 5% CO2. For each sample, the cell line was plated 
with a density of 7.5×103 cells/well for MCF7 and HCT15 or 1.0×104 cells/well for 
HeLa and HepG2 in 96-well plates.   
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Furthermore, a hepatotoxicity evaluation was conducted, using a cell culture prepared 
from fresh liver of a pig, which was slaughtered in a certified facility. This methodology 
was conducted, according to the authors Abreu et al. (2011). Before confluence was 
reached, and by monitoring the growth with a phase-contrast microscope every day, the 
cell culture was sub-cultured and also plated in a 96 well plat, using a density of 
1.0×104 cells/well. DMEM medium with 10% FBS, 100 U/mL penicillin and 100 
µg/mL streptomycin was added, and once again ellipticine was used as positive control. 
Finally, the results were expressed in GI50 values (sample concentration that inhibited 
50% of the net cell growth).  
 
2.4. Antibacterial activity 
For the antibacterial activity, the procedure previously described by Espinel-Ingroff, 
(2001) was followed. The following Gram-negative bacteria were used: Escherichia 
coli (ATCC 35210), Pseudomonas aeruginosa (ATCC (American type culture 
collection) 27853), Salmonella typhimurium (ATCC 13311), Enterobacter cloacae 
(ATCC 35030), and Gram-positive bacteria: Staphylococcus aureus (ATCC 6538), 
Bacillus cereus (clinical isolate), Micrococcus flavus (ATCC 10240), and Listeria 
monocytogenes (NCTC (National collection of type cultures) 7973). The minimum 
inhibitory (MIC) and minimum bactericidal (MBC) concentrations were determined by 
the microdilution method. The bacterial colony forming unites (CFU)/mL were cultured 
overnight and adjusted at a concentration of 1×105 CFU/mL, using a spectrophotometer 
at 625 nm. In order to determine the absence of contamination, the inocula were 
cultured on a solid medium. The sample solutions were pipetted into the wells 
containing 100 µL of Tryptic Soy Broth (TSB) and afterwards, 10 µL of inoculum was 
added to all the wells. After incubating the microplates at 37 °C for 24h the MIC were 
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determined by adding 40 µL of iodonitrotetrazolium chloride (INT) (0.2 mg/mL) with 
posterior incubation at 37 °C for 30 min. The lowest concentration that produced a 
significant inhibition (around 50%) of the growth of the bacteria in comparison with the 
positive control was identified as the MIC. The MICs obtained from the susceptibility 
of the various bacteria were also tested with a colorimetric assay, which is based on the 
reduction of a INT color and compared with positive control for each bacterial strains 
(CLSI, 2009). Finally, the lowest concentration with no growth was regarded as the 
MBC and was determined by serial sub-cultivation of 10 µL into microplates containing 
100 µL of TSB. Streptomycin and Ampicillin were used a positive controls, while 5% 
Dimethyl sulfoxide (DMSO) was used as negative control.  
 
2.5. Antifungal activity  
For the antifungal activity, the procedure previously described by Booth (1971) was 
followed, using the following microfungi: Aspergillus fumigatus (ATCC 1022), 
Aspergillus ochraceus (ATCC 12066), Aspergillus versicolor (ATCC 11730), 
Aspergillus niger (ATCC 6275), Trichoderma viride (IAM (Culture Collection, Center 
for Cellular and Molecular Research, Institute of Molecular and Cellular Biosciences, 
The University of Tokyo, Japan) 5061), Penicillium funiculosum (ATCC 36839), 
Penicillium ochrochloron (ATCC 9112) and Penicillium verrucosum var. cyclopium 
(food isolate). The micromycetes were maintained on malt agar (MA) and the cultures 
were stored at 4 °C and sub-cultured once a month.  
Initially, the fungal spores were washed from the surface of agar plates with sterile 
0.85% saline containing 0.1% Tween 80 (v/v). The spore suspension was adjusted with 
sterile saline to a concentration of approximately 1.0 × 105 in a final volume of 100 
µL/well, and the inocula were stored at 4° C for further use. To verify the absence of 
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contamination, dilutions of the inocula were cultured on solid MA. To determine the 
MICs, serial dilutions were used, wih 96-well microplates. Furthermore, the sample 
solutions were added to broth malt medium with the fungal inoculum. The microplates 
were incubated for 72 h at 28 °C. The MICs were defined as the lowest concentrations 
without visible growth, determined through a binocular microscope. The minimum 
fungicidal concentrations (MFC) were determined by serial sub-cultivation of 2 µL in 
microtitre plates containing 100 µL of malt broth per well and further incubation for 72 
h at 28 °C. The lowest concentration with no visible growth was defined as the MFC, 
which indicated that 99.5% of the original inoculum was killed. DMSO at 5% was used 
as a negative control, while bionazole and ketokonazole were used as positive controls. 
 
2.6. Statistical analysis  
All the assays were carried out in triplicate for both decoctions and infusions of each 
cultivar. A Tukey’s honestly significant difference post hoc test with α = 0.05 preceded 
of a one-way analysis of variance (ANOVA) result in the different letters seen in the 
tables, and the results were expressed as mean values ± standard deviations (SD). The 
statistical analysis was carried out using the SPSS v. 20.0 program.   
 
3. Results and Discussion 
3.1. Antitumor activity 
The values of the GI50 of the antitumor activity of the samples are detailed in Table 1. 
Ellipticine, a very strong antitumor compound which intercalates with DNA and inhibits 
topoisomerase II was used as a positive control. None of the extracts showed inhibition 
towards the non-tumor liver primary culture (PLP2), corroborating the security of the 
consumption of these flowers. The tested human tumor cell lines of breast, colon, 
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cervical, and liver carcinoma are some of the most used for primary antitumor 
screening. No effect was detected at the highest concentration in any sample towards the 
HeLa cervical cancer cell line. For the MCF7, breast cancer, all the samples had the 
same effect with no statistical differences, while for the HCT15 colon carcinoma, 
decoction of Judia (DJ) was the most effective. For the cell line HepG2, the activity of 
Longal was significantly lower than the one observed for Judia, regardless of the 
extraction method. The in vitro antitumor activity observed could be related to the 
presence of trigalloyl-HHDP-glucoside, followed by pentagalloyl glucoside, the two 
main polyphenols detected in the flowers, belonging to the ellagitannins family, which 
has shown antitumor activity in vitro. Pentagalloyl glucoside can act as a proapoptotic, 
anti-proliferative, anti-angiogenic and anti-metastasic compound and has been used in 
prostate, lung, breast cancer as well as sarcoma (Zhang et al., 2009). Although the 
antitumor potential was not as low as ellipticine, the results were very close to the GI50 
of other natural plant extracts (Guimarães et al., 2013), and in some cases even better 
(Santos et al., 2013). Moreover and contrarily to ellipticine, the samples did not show 
any toxicity for non-tumor cells. 
 
 
3.2. Antibacterial activity 
The antibacterial activity towards different Gram-positive and Gram-negative bacteria, 
of the different samples is displayed in Table 2. Regarding the MIC’s, which represent 
the minimum concentration to inhibit the growth of a colony overnight, all the samples 
had lower values than the positive control ampicillin, which is quite satisfactory. For E. 
coli and E. cloacae, all the samples also had lower values that streptomycin. For S. 
typhimurium, infusion of Judia (IJ), DJ, and infusion of Longal (IL) displayed lower 
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values than streptomycin, while DL had the same value. For B. cereus, the minimum 
inhibition level of IJ was lower than the antibiotic, while in DJ and IL the values were 
the same. For M. flavus, IL was the only sample with higher values that streptomycin. In 
all other cases, the antibiotic had lower inhibition concentrations. Overall, the 
decoctions proved better antibacterial effects with eight lowest MIC values, while 
infusions only displayed five. In terms of MBC, the bactericidal effects of the samples 
were quite interesting. Except IJ in S. aereus and IL in M. flavus, all the other extracts 
had lower MBC’s than ampicillin. Furthermore, for S. typhimurium, E. coli and E. 
cloacae, all the samples also had lower values than streptomycin. DJ and IL displayed 
the same MBC as streptomycin for S. aureus and B. cereus, along with decoction of 
Longal (DL) in the latter. The lowest values of MBC were quite well spread throughout 
the four samples, with each one having the same number of lowest concentrations for 
different bacteria. The better results found in the MIC’s of decoctions could be related 
to the higher quantity of trigalloyl-HHDP-glucoside, quercetin-3-O-glucuronide, the 
higher amounts of organic acids and better antioxidant results (Carocho et al., 2014). 
 
 
 
3.3. Antifungal activity 
The antifungal activity of the samples is shown in Table 3. Bifonazole had lower MIC’s 
and MFC’s values when compared to ketoconazole for all species, with exception of P. 
funiculosum, in which both synthetic antifungal drugs had MIC=0.2 mg/mL. Regarding 
the MIC’s, for A. fumigatus, all but IL had higher values than both the positive controls, 
which had the same value as ketoconazole. For A. versicolor, IJ, DJ and DL displayed 
the same MIC as ketoconazole. All samples had better results than ketoconazole for A. 
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ochraceus, but only IJ had lower values than bifonazole. The best sample for A. niger 
was IL, along with T. viride and P. funiculosum. For P. verrucosum, all the samples had 
higher concentrations when compared to both positive controls. Overall, the best sample 
was IL, with the lower concentration needed to inhibit a greater number of fungi. 
Concerning MFC’s, the samples had lower fungicidal concentrations than ketoconazole 
for A. fumigatus, A. ochraceus, A. niger, T. viride, and P. ochrochloron, while in A. 
versicolor, and P. verrucosum all samples had higher concentrations. For bifonazole, 
the samples also displayed higher concentrations in A. fumigatus, A. versicolor, and P. 
verrucosum. Generally, the infusions, mainly of Longal, had the lower fungicidal 
concentration in most of the analysed fungi. While the decoctions had better effect as 
antibacterial agents, the infusions proved to be more effective against fungi, especially 
the cultivar Longal. In terms of phenolic composition, antioxidant activity and presence 
of organic acids, the infusions were quite poor when compared to the decoctions 
(Carocho et al., 2014), which means the fungicidal compounds could be sensitive to 
heat extraction (lower periods of heat for infusions) and other studies should be carried 
out with cold extractions. These results are in line with other natural plant matrices, like 
Laurus nobilis, which had very similar activity against the same species of fungi (Dias 
et al., 2014). In terms of cultivars, Longal seems to have higher antimicrobial activity 
than Judia, regardless of the extraction method, especially against fungi. 
 
4. Conclusion	  
Overall, the decoctions seemed to be better against HCT15 and HepG2 cancer cell lines 
as well as against bacteria. The infusions seemed more suitable against fungi. This 
manuscript brings some more proof and further corroborates the claims of the benefits 
of consumption of chestnut flowers for some illnesses. The antitumor activity, and lack 
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of toxicity towards normal cells reassures the safety of consumption while the 
antimicrobial activity confers some applicability of these flowers in the food processing 
chain to be used as natural antimicrobials. Further research of individual compounds 
could be carried out to determine their individual contribution for each activity. 
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